Helius Medical Technologies, Inc. (HSDT)
USD 0.4
(-2.44%)
USD 0.4
(-2.44%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -12.1 Million USD | 24.76% |
| 2022 | -14.5 Million USD | 10.36% |
| 2021 | -17.82 Million USD | -27.35% |
| 2020 | -13.9 Million USD | 62.83% |
| 2019 | -23.93 Million USD | -54.14% |
| 2018 | -26.61 Million USD | -39.29% |
| 2017 | -17.66 Million USD | -105.48% |
| 2016 | -8.59 Million USD | 2.8% |
| 2015 | -6.83 Million USD | -728.7% |
| 2014 | -1.06 Million USD | 87.47% |
| 2013 | -8.51 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -3.4 Million USD | -52.81% |
| 2024 Q2 | -3.27 Million USD | 3.82% |
| 2023 Q2 | -4.65 Million USD | 6.47% |
| 2023 Q1 | -4.97 Million USD | -1449.84% |
| 2023 Q4 | -2.22 Million USD | -0.32% |
| 2023 Q3 | -2.21 Million USD | 52.33% |
| 2023 FY | - USD | 24.76% |
| 2022 Q3 | -4.02 Million USD | -35.16% |
| 2022 Q1 | -4.7 Million USD | -16.13% |
| 2022 Q4 | -321 Thousand USD | 92.02% |
| 2022 FY | - USD | 10.36% |
| 2022 Q2 | -2.97 Million USD | 36.76% |
| 2021 Q3 | -3.98 Million USD | 36.65% |
| 2021 FY | - USD | -27.35% |
| 2021 Q1 | -3.54 Million USD | -4.3% |
| 2021 Q2 | -6.28 Million USD | -77.66% |
| 2021 Q4 | -4.05 Million USD | -1.78% |
| 2020 Q4 | -3.39 Million USD | 9.4% |
| 2020 Q1 | -3.07 Million USD | 46.89% |
| 2020 Q2 | -3.9 Million USD | -26.97% |
| 2020 Q3 | -3.74 Million USD | 4.15% |
| 2020 FY | - USD | 62.83% |
| 2019 Q1 | -14.93 Million USD | -176.03% |
| 2019 FY | - USD | -54.14% |
| 2019 Q4 | -5.79 Million USD | 0.62% |
| 2019 Q3 | -5.83 Million USD | 48.87% |
| 2019 Q2 | -11.4 Million USD | 23.63% |
| 2018 Q3 | -5.24 Million USD | 9.25% |
| 2018 FY | - USD | -39.29% |
| 2018 Q2 | -5.77 Million USD | 29.57% |
| 2018 Q1 | -8.2 Million USD | -2.49% |
| 2018 Q4 | -5.41 Million USD | -3.22% |
| 2017 FY | - USD | -105.48% |
| 2017 Q1 | -5.03 Million USD | -184.54% |
| 2017 Q2 | -5.98 Million USD | -18.8% |
| 2017 Q3 | 998 Thousand USD | 116.69% |
| 2017 Q4 | -8 Million USD | -901.7% |
| 2016 Q2 | -1.99 Million USD | 31.58% |
| 2016 FY | - USD | 2.8% |
| 2016 Q1 | -2.91 Million USD | -7.22% |
| 2016 Q4 | -1.76 Million USD | 53.37% |
| 2016 Q3 | -3.79 Million USD | -90.21% |
| 2015 Q1 | 4.02 Million USD | 197.88% |
| 2015 Q4 | -2.71 Million USD | -162.97% |
| 2015 FY | - USD | -728.7% |
| 2015 Q3 | -1.03 Million USD | 63.53% |
| 2015 Q2 | -2.83 Million USD | -170.43% |
| 2014 Q2 | -1.56 Million USD | -159.21% |
| 2014 Q1 | -602.42 Thousand USD | -80.58% |
| 2014 Q3 | -2.75 Million USD | -76.3% |
| 2014 Q4 | -4.11 Million USD | -49.37% |
| 2014 FY | - USD | 87.47% |
| 2013 Q2 | -63.98 Thousand USD | 0.0% |
| 2013 FY | - USD | 0.0% |
| 2013 Q3 | -67.28 Thousand USD | -5.15% |
| 2013 Q4 | -333.59 Thousand USD | -395.84% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Acutus Medical, Inc. | -13.48 Million USD | 10.232% |
| Cerus Corporation | -26.53 Million USD | 54.375% |
| OrthoPediatrics Corp. | -8.38 Million USD | -44.458% |
| PetVivo Holdings, Inc. | -10.49 Million USD | -15.365% |
| Talis Biomedical Corporation | -66.04 Million USD | 81.669% |
| Vivos Therapeutics, Inc. | -16.67 Million USD | 27.394% |
| Inogen, Inc. | -45.67 Million USD | 73.495% |
| Spectral AI, Inc. | -12.26 Million USD | 1.264% |
| Nano-X Imaging Ltd. | -47.69 Million USD | 74.615% |
| CVRx, Inc. | -38.73 Million USD | 68.741% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | -243.169% |
| Orthofix Medical Inc. | -86.98 Million USD | 86.082% |
| Venus Concept Inc. | -26.11 Million USD | 53.636% |
| Accelerate Diagnostics, Inc. | -49.77 Million USD | 75.675% |
| Bioventus Inc. | -23.07 Million USD | 47.521% |
| BrainsWay Ltd. | -2.31 Million USD | -423.886% |
| Envoy Medical, Inc. | -18.23 Million USD | 33.617% |
| electroCore, Inc. | -17.76 Million USD | 31.83% |
| IceCure Medical Ltd | -15.25 Million USD | 20.625% |
| Lucid Diagnostics Inc. | -49.75 Million USD | 75.665% |
| Monogram Orthopaedics, Inc. | -16.85 Million USD | 28.173% |
| MaxCyte, Inc. | -44.12 Million USD | 72.564% |
| NeuroOne Medical Technologies Corporation | -11.75 Million USD | -2.986% |
| Nexalin Technology, Inc. | -5.69 Million USD | -112.7% |
| PAVmed Inc | -75.74 Million USD | 84.015% |
| Rapid Micro Biosystems, Inc. | -53.75 Million USD | 77.479% |
| RxSight, Inc. | -41.03 Million USD | 70.497% |
| Sight Sciences, Inc. | -49.41 Million USD | 75.499% |
| SI-BONE, Inc. | -34.44 Million USD | 64.852% |
| TELA Bio, Inc. | -40.63 Million USD | 70.204% |
| TriSalus Life Sciences, Inc. | -58.29 Million USD | 79.233% |
| Treace Medical Concepts, Inc. | -39 Million USD | 68.963% |
| LivaNova PLC | 39.01 Million USD | 131.031% |
| 908 Devices Inc. | -34.02 Million USD | 64.417% |
| Alphatec Holdings, Inc. | -110.59 Million USD | 89.053% |
| Nemaura Medical Inc. | -7.28 Million USD | -66.144% |
| NeuroPace, Inc. | -22.83 Million USD | 46.978% |
| LENSAR, Inc. | -8.71 Million USD | -38.937% |
| Apyx Medical Corporation | -18.11 Million USD | 33.155% |
| Cutera, Inc. | -136.56 Million USD | 91.134% |
| STRATA Skin Sciences, Inc. | -3.38 Million USD | -258.195% |
| BioSig Technologies, Inc. | -28.15 Million USD | 56.993% |
| Anika Therapeutics, Inc. | 2.51 Million USD | 581.2% |
| ClearPoint Neuro, Inc. | -20.98 Million USD | 42.317% |
| Integra LifeSciences Holdings Corporation | 383.56 Million USD | 103.156% |
| Axonics, Inc. | 7.77 Million USD | 255.717% |
| Outset Medical, Inc. | -153.78 Million USD | 92.128% |
| IRIDEX Corporation | -7.44 Million USD | -62.554% |
| PROCEPT BioRobotics Corporation | -98.09 Million USD | 87.658% |
| IRadimed Corporation | 20.8 Million USD | 158.205% |
| Tivic Health Systems, Inc. | -8.06 Million USD | -50.174% |
| INVO Bioscience, Inc. | -6.88 Million USD | -75.973% |
| Telesis Bio, Inc. | -40.49 Million USD | 70.101% |
| Viemed Healthcare, Inc. | 36.67 Million USD | 133.01% |
| Varex Imaging Corporation | 67.2 Million USD | 118.016% |
| Quipt Home Medical Corp. | 44.07 Million USD | 127.472% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | -11.38% |
| Pulmonx Corporation | -55.09 Million USD | 78.024% |
| Dynatronics Corporation | -976 Thousand USD | -1140.461% |
| Modular Medical, Inc. | -17.1 Million USD | 29.211% |
| ReShape Lifesciences Inc. | -14.48 Million USD | 16.417% |
| Semler Scientific, Inc. | 23.58 Million USD | 151.325% |
| InMode Ltd. | 196.28 Million USD | 106.168% |
| Bruker Corporation | 599 Million USD | 102.021% |
| Cytosorbents Corporation | -28.81 Million USD | 57.978% |
| DexCom, Inc. | 916.7 Million USD | 101.321% |
| Align Technology, Inc. | 799.03 Million USD | 101.515% |
| Viveve Medical, Inc. | -20.61 Million USD | 41.277% |
| ZimVie Inc. | 91.07 Million USD | 113.294% |
| Movano Inc. | -29.12 Million USD | 58.431% |
| Cytek Biosciences, Inc. | -4.4 Million USD | -174.66% |
| Nexalin Technology, Inc. | -5.69 Million USD | -112.7% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -243.169% |
| Tandem Diabetes Care, Inc. | -194.65 Million USD | 93.78% |
| Profound Medical Corp. | -27.12 Million USD | 55.363% |
| Insulet Corporation | 323.6 Million USD | 103.741% |
| enVVeno Medical Corporation | -25.01 Million USD | 51.607% |
| Surmodics, Inc. | 1.18 Million USD | 1119.108% |
| iCAD, Inc. | -6.56 Million USD | -84.417% |
| Nuwellis, Inc. | -16.35 Million USD | 25.978% |
| Biotricity, Inc. | -8.82 Million USD | -37.139% |
| iRhythm Technologies, Inc. | -96.86 Million USD | 87.501% |
| Aethlon Medical, Inc. | -11.84 Million USD | -2.176% |
| InspireMD, Inc. | -20.91 Million USD | 42.102% |
| PAVmed Inc. | -75.74 Million USD | 84.015% |
| BIOLASE, Inc. | -15.13 Million USD | 20.028% |
| Beyond Air, Inc. | -59.03 Million USD | 79.49% |
| FONAR Corporation | 28.25 Million USD | 142.854% |
| AxoGen, Inc. | -13.32 Million USD | 9.161% |
| Vivani Medical, Inc. | -26.6 Million USD | 54.499% |
| Tactile Systems Technology, Inc. | 24.54 Million USD | 149.334% |
| Inari Medical, Inc. | 7.11 Million USD | 270.209% |
| UFP Technologies, Inc. | 72.74 Million USD | 116.644% |
| QT Imaging Holdings, Inc. | -3.38 Million USD | -257.583% |
| Heart Test Laboratories, Inc. | -6.15 Million USD | -96.67% |
| Tenon Medical, Inc. | -15.52 Million USD | 22.031% |
| Autonomix Medical, Inc. Common Stock | -15.26 Million USD | 20.693% |
| Co-Diagnostics, Inc. | -41.47 Million USD | 70.809% |
| AdaptHealth Corp. | -171.09 Million USD | 92.924% |
| Sintx Technologies, Inc. | -6.6 Million USD | -83.439% |
| NanoVibronix, Inc. | -3.43 Million USD | -252.46% |
| Quanterix Corporation | -38.08 Million USD | 68.213% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | -11.38% |
| Sensus Healthcare, Inc. | 30 Thousand USD | 40456.667% |
| Pacific Biosciences of California, Inc. | -277.28 Million USD | 95.634% |
| TransMedics Group, Inc. | -7.6 Million USD | -59.24% |
| ReWalk Robotics Ltd. | -21.76 Million USD | 44.374% |
| NeuroMetrix, Inc. | -7.09 Million USD | -70.622% |
| Hyperfine, Inc. | -47.06 Million USD | 74.274% |
| Establishment Labs Holdings Inc. | -58.3 Million USD | 79.236% |
| Biomerica, Inc. | -5.99 Million USD | -102.019% |
| Bone Biologics Corporation | 479.57 Thousand USD | 2624.543% |
| AVITA Medical, Inc. | -39.56 Million USD | 69.402% |
| Bluejay Diagnostics, Inc. | -9.17 Million USD | -31.986% |
| Silk Road Medical, Inc | -45.08 Million USD | 73.143% |